1-3 of 3
Diana Mittag
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Potency and Selectivity of BTK Inhibitors in Clinical Development for B-Cell Malignancies

Allard Kaptein, Gerjan de Bruin, Maaike Emmelot-van Hoek, Bas van de Kar, Anouk de Jong, Michael Gulrajani, Dennis Demont, Todd Covey, PhD, Diana Mittag, Tjeerd Barf
Journal: Blood
Blood (2018) 132 (Supplement 1): 1871.
https://doi.org/10.1182/blood-2018-99-109973
Published: 2018
Journal Articles

Pharmacodynamic Evaluation of Acalabrutinib in Relapsed/Refractory and Treatment-Naive Patients with Chronic Lymphocytic Leukemia (CLL) in the Phase 1/2 ACE-CL-001 Study

Todd Covey, PhD, Michael Gulranjani, Jean Cheung, Elena Bibikova, Tracy Clevenger, Fanny Krantz, Karen Pan, Kyoko Yamaguchi, Anouk De Jong, Bart Van Lith, Diana Mittag, Raquel Izumi, PhD, John C. Byrd, MD, William G Wierda, MD PhD, Susan M. O'Brien, MD, Richard R. Furman, MD, Allard Kaptein, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1741.
https://doi.org/10.1182/blood.V130.Suppl_1.1741.1741
Published: 2017
Journal Articles

acDCs enhance human antigen–specific T-cell responses

Emanuela Martinuzzi, Georgia Afonso, Marie-Claude Gagnerault, Gaetano Naselli, Diana Mittag, Béhazine Combadière, Christian Boitard, Nathalie Chaput, Laurence Zitvogel, Leonard C. Harrison, Roberto Mallone
Journal: Blood
Blood (2011) 118 (8): 2128–2137.
https://doi.org/10.1182/blood-2010-12-326231
Published: 2011
Includes: Supplemental data